EX-99.5 6 dex995.htm LICENSE AND ROYALTY AGRMT. BY & AMONG PFIZER INC., MEDAREX, INC. & GENPHARM INTL LICENSE AND ROYALTY AGREEMENTLicense and Royalty Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis LICENSE AND ROYALTY AGREEMENT is entered into as of April 4, 2003 (the “Effective Date”) by and between PFIZER INC a Delaware corporation, having an office at 235 East 42nd Street, New York, New York 10017 and its Affiliates (“Pfizer”) and MEDAREX, INC., a New Jersey corporation, with a principal place of business at 707 State Road, Princeton, New Jersey 08540, and GENPHARM INTERNATIONAL, INC., a wholly owned subsidiary of Medarex, Inc., (together “Medarex”);
LICENSE AND ROYALTY AGREEMENTLicense and Royalty Agreement • November 8th, 2004 • Medarex Inc • Services-commercial physical & biological research • New York
Contract Type FiledNovember 8th, 2004 Company Industry JurisdictionThis LICENSE AND ROYALTY AGREEMENT is entered into as of April 4, 2003 (the “Effective Date”) by and between PFIZER INC a Delaware corporation, having an office at 235 East 42nd Street, New York, New York 10017 and its Affiliates (“Pfizer”) and MEDAREX, INC., a New Jersey corporation, with a principal place of business at 707 State Road, Princeton, New Jersey 08540, and GENPHARM INTERNATIONAL, INC., a wholly owned subsidiary of Medarex, Inc., (together “Medarex”);